APA (7th ed.) Citation

SR, S., FJ, A., DL, S., JM, M., I, H., N, G., . . . S, A. (2021). Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study. EClinicalMedicine, 42, 101190. https://doi.org/10.1016/j.eclinm.2021.101190

Chicago Style (17th ed.) Citation

SR, Singer, et al. "Effectiveness of BNT162b2 MRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in Israel: A Prospective Cohort Study." EClinicalMedicine 42 (2021): 101190. https://doi.org/10.1016/j.eclinm.2021.101190.

MLA (9th ed.) Citation

SR, Singer, et al. "Effectiveness of BNT162b2 MRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in Israel: A Prospective Cohort Study." EClinicalMedicine, vol. 42, 2021, p. 101190, https://doi.org/10.1016/j.eclinm.2021.101190.